Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product
- PMID: 2180064
- DOI: 10.1126/science.2180064
Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product
Abstract
The tat-responsive region (TAR) of the human immunodeficiency virus-1 (HIV-1) exhibits a trans-inhibitory effect on translation in vitro by activating the interferon-induced 68-kilodalton protein kinase (p68 kinase). Productive infection by HIV-1 was shown to result in a significant decrease in the amount of cellular p68 kinase. The steady-state amount of p68 kinase was also reduced in interferon-treated HeLa cell lines stably expressing tat, as compared to the amount of the kinase in interferon-treated control HeLa cells. Thus, the potential translational inhibitory effects of the TAR RNA region mediated by activation of p68 kinase may be downregulated by tat during productive HIV-1 infection.
Similar articles
-
The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence of RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase.J Virol. 1991 Feb;65(2):632-40. doi: 10.1128/JVI.65.2.632-640.1991. J Virol. 1991. PMID: 1702840 Free PMC article.
-
Binding of Tat protein to TAR region of human immunodeficiency virus type 1 blocks TAR-mediated activation of (2'-5')oligoadenylate synthetase.AIDS Res Hum Retroviruses. 1990 May;6(5):659-72. doi: 10.1089/aid.1990.6.659. AIDS Res Hum Retroviruses. 1990. PMID: 1694453
-
Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2',5'-oligoadenylate synthetase hybrid gene.FASEB J. 1990 Oct;4(13):3124-30. doi: 10.1096/fasebj.4.13.1698680. FASEB J. 1990. PMID: 1698680
-
Regulation of expression of human immunodeficiency virus.New Biol. 1990 Jan;2(1):20-31. New Biol. 1990. PMID: 2078551 Review.
-
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.Adv Pharmacol. 2000;48:209-27. doi: 10.1016/s1054-3589(00)48007-5. Adv Pharmacol. 2000. PMID: 10987092 Review. No abstract available.
Cited by
-
Translation-targeted therapeutics for viral diseases.Gene Expr. 1995;4(6):357-67. Gene Expr. 1995. PMID: 7549467 Free PMC article. Review.
-
Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.J Virol. 1995 Jun;69(6):3584-96. doi: 10.1128/JVI.69.6.3584-3596.1995. J Virol. 1995. PMID: 7745706 Free PMC article.
-
Relative resistance of HIV-1 founder viruses to control by interferon-alpha.Retrovirology. 2013 Dec 3;10:146. doi: 10.1186/1742-4690-10-146. Retrovirology. 2013. PMID: 24299076 Free PMC article.
-
Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase.Proc Natl Acad Sci U S A. 1990 Nov;87(22):8687-91. doi: 10.1073/pnas.87.22.8687. Proc Natl Acad Sci U S A. 1990. PMID: 2247437 Free PMC article.
-
Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR.J Virol. 1999 Aug;73(8):7080-6. doi: 10.1128/JVI.73.8.7080-7086.1999. J Virol. 1999. PMID: 10400814 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources